Atara Biotherapeutics, Inc. Liquidation Value

ATRA Other

Cash & Equivalents

$8.48M
As of 2025-12-31
Current Price: $4.90 (as of 2026-04-24)

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $8.48M
Total Obligations: -$25.30M
$-16.82M
Per share: $-2.30
Period: 2025-12-31

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $8.48M
AR: $1.25M
Total Obligations: -$25.30M
$-15.56M
Per share: $-2.12
Period: 2025-12-31

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $8.48M
AR: $1.25M
Inventory: $0
Total Obligations: -$25.30M
$-15.56M
Per share: $-2.12
Period: 2025-12-31

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$-16.82M$-2.30
Liquid Liquidation Value$-15.56M$-2.12
Operating Liquidation Value$-15.56M$-2.12

Key Components (as of 2025-12-31)

Cash & Equivalents$8.48M
Accounts Receivable$1.25M
Inventory$0
Current Liabilities$14.92M
Long-term DebtN/A
Op. Lease Liability$10.38M
Finance Lease$0
Shares Outstanding7.3M

Explore all 173 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2025-12-31$8.48M$1.25M$0$127,000$14.92MN/A$10.38M$0
2025-09-30$5.74M$1.91M$0$318,000$18.06MN/A$16.96M$0
2025-06-30$16.90M$0$0$1.76M$14.56MN/A$17.67M$0
2025-03-31$13.84M$8.88M$0$1.38M$47.89MN/A$39.55M$2.39M
2024-12-31$25.03M$1.48M$10.65M$4.37M$134.57MN/A$42.79M$2.64M
2024-09-30$46.45M$1.33M$13.98M$2.15M$155.98MN/A$48.90M$1.01M
2024-06-30$31.31M$2.42M$18.75M$5.25M$148.27MN/A$51.73M$975,000
2024-03-31$35.09M$35.83M$16.08M$2.85M$180.69MN/A$55.28M$945,000

Comments

SEC Filings

PeriodFormFiledLink
2025-12-31 10-K 2026-03-16 View
2025-09-30 10-Q 2025-11-12 View
2025-06-30 10-Q 2025-08-11 View
2025-03-31 10-Q 2025-05-15 View
2024-12-31 10-K 2025-03-07 View
2024-09-30 10-Q 2024-11-12 View
2024-06-30 10-Q 2024-08-12 View
2024-03-31 10-Q 2024-05-09 View

Community Notes

Loading notes...

Questions

Loading questions...